Guangzhou Kingmed Diagnostics Group Co Ltd - Asset Resilience Ratio
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has an Asset Resilience Ratio of 0.14% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (None–None)
This chart shows how Guangzhou Kingmed Diagnostics Group Co Ltd's Asset Resilience Ratio has changed over time. Check 603882 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Guangzhou Kingmed Diagnostics Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangzhou Kingmed Diagnostics Group Co L stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥12.77 Million | 0.14% |
| Total Liquid Assets | CN¥12.77 Million | 0.14% |
Asset Resilience Insights
- Limited Liquidity: Guangzhou Kingmed Diagnostics Group Co Ltd maintains only 0.14% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangzhou Kingmed Diagnostics Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangzhou Kingmed Diagnostics Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
LONZA GROUP UNSP.ADR 1/10
F:LO3A |
Diagnostics & Research | 3.04% |
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
Diagnostics & Research | 13.43% |
|
BGI Genomics Co Ltd
SHE:300676 |
Diagnostics & Research | 3.62% |
|
Fleury S.A.
SA:FLRY3 |
Diagnostics & Research | 16.06% |
|
Centro de Imagem Diagnósticos S.A
SA:AALR3 |
Diagnostics & Research | 4.77% |
|
Inoviq Ltd
AU:IIQ |
Diagnostics & Research | 56.29% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Immunovia publ AB
ST:IMMNOV |
Diagnostics & Research | 83.99% |
Annual Asset Resilience Ratio for Guangzhou Kingmed Diagnostics Group Co Ltd (None–None)
The table below shows the annual Asset Resilience Ratio data for Guangzhou Kingmed Diagnostics Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.